Trial intelligence / Profile preview

Midazolam intranasal spray pharmacokinetics and pharmacodynamics in elderly volunteers

NL-OMON49143Active, not recruiting

Sponsor
QPS
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of midazolam in Not applicable, sponsored by QPS. Primary endpoints: Population pharmacokinetic-pharmacodynamic model development, Pharmacokinetic model parameters and 2 more. Started Mar 2020; status: active, not recruiting.

02

Drugs

midazolam
03

Conditions

Not applicable

Beyond the preview

Go deeper on NL-OMON49143.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON49143.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call